|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 591 active entries
Vedbęk DK-2950 , Denmark
Phone: (+45) 45 66 08 88
Fax: (+45) 45 66 18 88
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Exiqon is a Danish biotech company focused on the development of enabling technology platforms and novel DNA- and immuno-diagnostic products against common genetic diseases, in particular, cardio-vascular, diabetic and other chronic and degenerative diseases. In other fields Exiqon is a potential technology partner for licensees Exiqon's IPR includes LNA (Locked Nucleic Acids) and a universal method for the covalent coupling of diagnostic molecules to solid supports.
Last update of this entry: September 23, 2008
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking